首页> 外文期刊>Tissue engineering, Part A >The Treatment Efficacy of Bone Tissue Engineering Strategy for Repairing Segmental Bone Defects Under Osteoporotic Conditions
【24h】

The Treatment Efficacy of Bone Tissue Engineering Strategy for Repairing Segmental Bone Defects Under Osteoporotic Conditions

机译:骨组织工程学修复骨质疏松症节段性骨缺损的治疗功效

获取原文
获取原文并翻译 | 示例
           

摘要

The potential of increasing bone mass and preventing fractures in osteoporosis using stem cell therapy is currently an area of intense focus. However, there are very little data available regarding the postfracture bony defect healing efficacy under osteoporotic conditions. This study aims to investigate whether critical-sized segmental bone defects in a rabbit model of osteoporosis could be repaired using an allogenic stem cell-based tissue engineering (TE) approach and to investigate the potential influence of osteoporosis on the treatment efficacy. Rabbit fetal bone marrow mesenchymal stem cells (BMSCs) were harvested and expanded in vitro. Decalcified bone matrix (DBM) scaffolds were then seeded with allogenic fetal BMSCs and cultivated in osteogenic media to engineer BMSC/DBM constructs. Critical-sized radial defects were created in ovariectomized (OVX) rabbits and the defects were repaired either by insertion of BMSC/DBM constructs or by DBM scaffolds alone. Also, nonovariectomized age-matched (non-OVX) rabbits were served as control. At 3 months post-treatment under the osteoporotic condition (OVX rabbits), the BMSC/DBM constructs inserted within the defect generated significantly more bone tissue when compared to the DBM scaffold as demonstrated by the X-ray, microcomputed tomography, and histological analyses. In addition, when compared to a normal nonosteoporotic condition (age-matched non-OVX rabbits), the defect treatment efficacy was adversely affected by the osteoporotic condition with significantly less bone regeneration. This study demonstrated the potential of allogenic fetal BMSC-based TE strategy for repairing bone defects in an osteoporotic condition. However, the treatment efficacy could be considerably compromised in the OVX animals. Therefore, a more sophisticated strategy that addresses the complicated pathogenic conditions associated with osteoporosis is needed.
机译:使用干细胞疗法增加骨量并预防骨质疏松症骨折的潜力目前是人们高度关注的领域。但是,关于骨质疏松条件下骨折后骨缺损愈合功效的数据很少。这项研究的目的是研究是否可以使用基于异体干细胞的组织工程(TE)方法修复兔骨质疏松症模型中的关键尺寸节段性骨缺损,并研究骨质疏松症对治疗功效的潜在影响。收获兔胎儿骨髓间充质干细胞(BMSC)并在体外扩增。然后将脱钙的骨基质(DBM)支架接种同种异体胎儿BMSC,并在成骨培养基中培养以改造BMSC / DBM构建体。在卵巢切除(OVX)兔中产生了严重的放射状缺损,并通过插入BMSC / DBM构建体或仅由DBM支架修复缺损。同样,将未切除卵巢的年龄匹配的(非OVX)兔作为对照。 X射线,显微计算机断层扫描和组织学分析显示,在骨质疏松条件下进行治疗后3个月(OVX兔),与DBM支架相比,插入到缺损中的BMSC / DBM构建体产生的骨组织明显更多。此外,当与正常的非骨质疏松症(年龄匹配的非OVX兔)相比时,骨质疏松症不利地影响了缺陷治疗的功效,而骨再生明显减少。这项研究证明了基于异体胎儿BMSC的TE策略在骨质疏松症中修复骨缺损的潜力。但是,在OVX动物中治疗效果可能会大大降低。因此,需要一种更复杂的策略来解决与骨质疏松症相关的复杂致病条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号